These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 16080251)

  • 1. Histone deacetylase activity and COPD.
    Bhowmik A
    N Engl J Med; 2005 Aug; 353(5):528-9; author reply 528-9. PubMed ID: 16080251
    [No Abstract]   [Full Text] [Related]  

  • 2. Decreased histone deacetylase activity in chronic obstructive pulmonary disease.
    Ito K; Ito M; Elliott WM; Cosio B; Caramori G; Kon OM; Barczyk A; Hayashi S; Adcock IM; Hogg JC; Barnes PJ
    N Engl J Med; 2005 May; 352(19):1967-76. PubMed ID: 15888697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone deacetylase activity and COPD.
    Lin AY
    N Engl J Med; 2005 Aug; 353(5):528-9; author reply 528-9. PubMed ID: 16079382
    [No Abstract]   [Full Text] [Related]  

  • 4. COPD unwound.
    Shapiro SD
    N Engl J Med; 2005 May; 352(19):2016-9. PubMed ID: 15888704
    [No Abstract]   [Full Text] [Related]  

  • 5. [The pathogenesis of chronic obstructive pulmonary disease, steroid resistance and the place of theophylline in the treatment].
    Bayram H
    Tuberk Toraks; 2009; 57(1):115-24. PubMed ID: 19533448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic regulation of airway inflammation.
    Adcock IM; Tsaprouni L; Bhavsar P; Ito K
    Curr Opin Immunol; 2007 Dec; 19(6):694-700. PubMed ID: 17720468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular basis of chronic inflammation in lung diseases: new therapeutic approach.
    Mroz RM; Noparlik J; Chyczewska E; Braszko JJ; Holownia A
    J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 2):453-60. PubMed ID: 18204158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pathogenesis of chronic obstructive pulmonary disease. Molecular mechanisms (part II)].
    Szulakowski P; Mróz RM; Pierzchała W; Chyczewska E; MacNee W
    Wiad Lek; 2006; 59(3-4):250-4. PubMed ID: 16813274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of protein acetylation in inflammatory lung diseases.
    Ito K; Charron CE; Adcock IM
    Pharmacol Ther; 2007 Nov; 116(2):249-65. PubMed ID: 17720252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corticosteroids: the drugs to beat.
    Barnes PJ
    Eur J Pharmacol; 2006 Mar; 533(1-3):2-14. PubMed ID: 16436275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concentration of matrix metalloproteinase-9 in serum of patients with chronic obstructive pulmonary disease and a degree of airway obstruction and disease progression.
    Brajer B; Batura-Gabryel H; Nowicka A; Kuznar-Kaminska B; Szczepanik A
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():145-52. PubMed ID: 19218638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced histone deacetylase in COPD: clinical implications.
    Barnes PJ
    Chest; 2006 Jan; 129(1):151-5. PubMed ID: 16424426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence of lower alteration of expiratory volume in patients with airflow limitation in the immediate period after lobectomy.
    Varela G; Brunelli A; Rocco G; Jiménez MF; Salati M; Gatani T
    Ann Thorac Surg; 2007 Aug; 84(2):417-22. PubMed ID: 17643609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E1A has no effect on LPS-induced IL-6 secretion in rat alveolar epithelial cells.
    Chen J; Luo J; Li B; Ran P
    Respiration; 2009; 78(1):84-92. PubMed ID: 19299891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone deacetylase HDAC1/HDAC2-controlled embryonic development and cell differentiation.
    Brunmeir R; Lagger S; Seiser C
    Int J Dev Biol; 2009; 53(2-3):275-89. PubMed ID: 19412887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of human calcium-activated chloride channel 1 is correlated with mucus overproduction in the airways of Chinese patients with chronic obstructive pulmonary disease.
    Wang K; Feng YL; Wen FQ; Chen XR; Ou XM; Xu D; Yang J; Deng ZP
    Chin Med J (Engl); 2007 Jun; 120(12):1051-7. PubMed ID: 17637221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Theophylline for COPD.
    Barnes PJ
    Thorax; 2006 Sep; 61(9):742-4. PubMed ID: 16936233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic capacity of the diaphragm in patients with COPD.
    Wijnhoven JH; Janssen AJ; van Kuppevelt TH; Rodenburg RJ; Dekhuijzen PN
    Respir Med; 2006 Jun; 100(6):1064-71. PubMed ID: 16257195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MMP-9 protein level does not reflect overall MMP activity in the airways of patients with COPD.
    Lowrey GE; Henderson N; Blakey JD; Corne JM; Johnson SR
    Respir Med; 2008 Jun; 102(6):845-51. PubMed ID: 18328682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of costameric proteins in the diaphragm of patients with chronic obstructive pulmonary disease.
    Wijnhoven JH; Hafmans T; Dekhuijzen PN
    Respiration; 2006; 73(4):529-37. PubMed ID: 16449803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.